Richard Söll
WuXi AppTec (China)(CN)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chemical Synthesis and Analysis, Myeloproliferative Neoplasms: Diagnosis and Treatment, Cytokine Signaling Pathways and Interactions, Retinal Diseases and Treatments
Most-Cited Works
- → Deep learning enables rapid identification of potent DDR1 kinase inhibitors(2019)1,401 cited
- → Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera(2008)381 cited
- → Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction(2004)321 cited
- → TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations(2007)282 cited
- → Discovery of MK‐8742: An HCV NS5A Inhibitor with Broad Genotype Activity(2013)196 cited
- → Selective Inhibition of JAK2-Driven Erythroid Differentiation of Polycythemia Vera Progenitors(2008)134 cited